Reflexiones sobre la resistencia a antibióticos y qué hacer al respecto

Hablar del uso y abuso de los antibióticos en un país como México, puede considerarse como algo que está de moda, pero lamentablemente y a pesar de los esfuerzos realizados es una práctica que continúa dejando consecuencias deletéreas e irreversibles. A partir del 27 de mayo de 2010 se publicó en el Diario Oficial de la Federación la Ley «para que únicamente se administren antibióticos cuando estos sean prescritos mediante receta emitida por los profesionales de la salud autorizados por ley, a fin de controlar su uso y abuso, y limitar las consecuencias negativas de una prescripción inadecuada, y contribuir a preservar la salud de los mexicanos». Múltiples fueron las razones para emitir esta ley, pero destaco 2:

• Publication year

  2016

• Venue

  Revista Portuguesa De Pneumologia

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.RGMX.2016.01.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Susceptibilidad de las bacterias aisladas de infecciones gastrointestinales agudas a la rifaximina y otros agentes antimicrobianos en México

  2016cited by this paper
• Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach

  2015cited by this paper
• Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review

  2014cited by this paper
• Antibiotic resistance in Mexico: a brief overview of the current status and its causes.

  2010cited by this paper
• Effects of Rifaximin on Bacterial Virulence Mechanisms at Supra- and Sub-Inhibitory Concentrations

  2008cited by this paper
• Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections

  2005cited by this paper
• Rifaximin, a Poorly Absorbed Antibiotic: Pharmacology and Clinical Potential

  2005cited by this paper
• SOS response promotes horizontal dissemination of antibiotic resistance genes

  2004cited by this paper
• Resistance gene transfer in anaerobes: new insights, new problems.

  1996cited by this paper

• Prevalence and impact of antimicrobial resistance in gastrointestinal infections: A review.

  2021cites this paper
• Prevalence and impact of antimicrobial resistance in gastrointestinal infections: A review.

  2021cites this paper
• Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide.

  2018cites this paper
• Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico

  2017cites this paper
• Susceptibility to rifaximin and other antimicrobials of bacteria isolated in patients with acute gastrointestinal infections in Southeast Mexico.

  2017cites this paper